IMMUNOLOGICA UK for Autoimmune diseases

IMMUNOLOGICAL provides a therapy developed in the Faculty of Pharmacy, University of Nottingham to reduce the progression of autoimmune diseases (multiple sclerosis, Crohn's disease, type 1 diabetes, psoriasis, rheumatoid arthritis), Allergy and asthma. This is an experimental therapy but the result expectations are amazing. IMMUNOLOGICA is a European company and we offer a therapy based in the hygiene hypothesis for Autoimmune diseases.

The hygiene hypothesis states that a lack of early childhood exposure to infectious agents, symbiotic microorganisms (e.g. gut flora or probiotics), and parasites increases susceptibility to allergic and Autoimmune diseases by modulating immune system development.

We are concentrating our effort to reduce the advance Multiple Sclerosis but our therapy has also shwon efectiviness in Asthma, alergy, crohn diseases, type 1 diabetes and psoriasis.

Extensive research and clinical trials have demonstrated the efectiviness of our therapies.

The therapy consist in the use of intestinal nematodes as probiotics. This nematodes produce a interesting modulation of the immune system that fix most of this autoimmune diseases.